UNBS5162 Inhibits Colon Cancer Growth via Suppression of PI3K/Akt Signaling Pathway

Medecine/Sciences - France
doi 10.1051/medsci/201834f117
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EDP Sciences

Related search

Acetylshikonin Inhibits Colorectal Cancer Growth via PI3K/Akt/mTOR Signaling Pathway

Chinese Medicine
2018English

Inhibition of Esophageal Cancer Growth Through the Suppression of PI3K/AKT/mTOR Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

PAQR3 Inhibits Proliferation via Suppressing PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer

Archives of Medical Science
Medicine
2018English

BMP9 Inhibits the Growth of Breast Cancer Cells by Downregulation of the PI3K/Akt Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

Diosgenin Inhibits Cell Proliferation of Primary Human Thyrocytes via Downregulation of PI3K/Akt Signaling Pathway

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2018English

Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway

Frontiers in Oncology
Cancer ResearchOncology
2020English

FOXP1 Regulation via the PI3K/Akt/p70S6K Signaling Pathway in Breast Cancer Cells

Oncology Letters
Cancer ResearchOncology
2015English

Ligustrazine Inhibits Platelet Activation via Suppression of the Akt Pathway

International Journal of Molecular Medicine
MedicineGenetics
2018English

Resveratrol Suppresses Colon Cancer Growth by Targeting the AKT/STAT3 Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy